![Ola Flink](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Ola Flink
Direttore/Membro del Consiglio presso
LIPIDOR AB
Profilo
Dr. Ola Flink is a Chairman at Ola Flink Consulting AB. He is on the Board of Directors at Lipidor AB, Biocelex Ltd. Oy and Eribis Pharmaceuticals AB. Dr. Flink was previously employed as an Investment Manager by Karolinska Development AB (Private Equity), a Vice President-Portfolio Management by Karolinska Development AB, a CMC Director by Axelar AB, a Chairman by BioChromix Pharma AB, a Chairman by Biosergen AS, a Chairman by Calabar International AB, a Chairman by KDev Exploratory AB, and a Chairman & Chief Executive Officer by OncoReg AB. He also served on the board at Akinion Pharmaceuticals AB, Asarina Pharma AB, BioCis Pharma Oy, Calabar AB, MarBiLeads AS, Oncopeptides AB and Umecrine Cognition AB.
Posizioni attive di Ola Flink
| Società | Posizione | Inizio |
|---|---|---|
| LIPIDOR AB | Direttore/Membro del Consiglio | 01/01/2020 |
Biocelex Ltd. Oy | Direttore/Membro del Consiglio | 21/04/2011 |
Eribis Pharmaceuticals AB
 Eribis Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology Develops and manufactures phramaceutical products | Direttore/Membro del Consiglio | - |
Ola Flink Consulting AB | Presidente | - |
Precedenti posizioni note di Ola Flink
| Società | Posizione | Fine |
|---|---|---|
BioCis Pharma Oy
 BioCis Pharma Oy Pharmaceuticals: MajorHealth Technology Develops and manufactures novel pharmaceutical products | Direttore/Membro del Consiglio | 01/05/2014 |
Calabar International AB
 Calabar International AB Pharmaceuticals: MajorHealth Technology Develops novel locally administered formulations against dry mouth | Presidente | 03/01/2014 |
Karolinska Development AB (Private Equity)
 Karolinska Development AB (Private Equity) Investment ManagersFinance Karolinska Development seeks investment in companies located in the Nordic region, primarily in Swedish. The firm targets companies operating in the fields of health technology, health services, medical devices, technology services, life science. It provides financing for early stage capital requirements. It takes a seat on the board of directors. | Investitore di Private Equity | 31/12/2013 |
OncoReg AB
 OncoReg AB Medical SpecialtiesHealth Technology Provides sensitizers and other related products for tumor treatment | Presidente | 20/01/2012 |
Axelar AB
 Axelar AB BiotechnologyHealth Technology Provides oral anti-cancer therapies | Direttore/Membro del Consiglio | 03/06/2010 |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
13
Relazioni di 1° grado
19
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 19 |
|---|---|
Karolinska Development AB (Private Equity)
Karolinska Development AB (Private Equity) Investment ManagersFinance Karolinska Development seeks investment in companies located in the Nordic region, primarily in Swedish. The firm targets companies operating in the fields of health technology, health services, medical devices, technology services, life science. It provides financing for early stage capital requirements. It takes a seat on the board of directors. | Finance |
Oncopeptides AB
 Oncopeptides AB Pharmaceuticals: MajorHealth Technology Develops chemotherapeutic pharmaceuticals of compounds for cancer treatment | Health Technology |
BioCis Pharma Oy
BioCis Pharma Oy Pharmaceuticals: MajorHealth Technology Develops and manufactures novel pharmaceutical products | Health Technology |
KDev Exploratory AB
 KDev Exploratory AB Miscellaneous Commercial ServicesCommercial Services Provides drug discovery solutions | Commercial Services |
Biosergen AS
 Biosergen AS BiotechnologyHealth Technology Operates as a biotechnology company which develops antifungal drugs for the treatment of severe invasive fungal infections | Health Technology |
Axelar AB
Axelar AB BiotechnologyHealth Technology Provides oral anti-cancer therapies | Health Technology |
Calabar AB
 Calabar AB Medical SpecialtiesHealth Technology Develops pharmaceutical products | Health Technology |
Eribis Pharmaceuticals AB
Eribis Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology Develops and manufactures phramaceutical products | Health Technology |
OncoReg AB
OncoReg AB Medical SpecialtiesHealth Technology Provides sensitizers and other related products for tumor treatment | Health Technology |
Lipidor AB
 Lipidor AB Miscellaneous Commercial ServicesCommercial Services Develops and commercializes lipid-based topical medication products | Commercial Services |
BioChromix Pharma AB
 BioChromix Pharma AB Miscellaneous Commercial ServicesCommercial Services Provides Alzheimer disease research services | Commercial Services |
Asarina Pharma AB
 Asarina Pharma AB Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
Umecrine Cognition AB
 Umecrine Cognition AB Pharmaceuticals: MajorHealth Technology Develops drug for neurological disorders of the brain | Health Technology |
Akinion Pharmaceuticals AB
 Akinion Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology Develops pharmaceutical for the treatment of acute myeloid leukemia | Health Technology |
Karolinska Development AB
 Karolinska Development AB Financial ConglomeratesFinance Operates as a life sciences investment company | Finance |
Biocelex Ltd. Oy | |
Calabar International AB
Calabar International AB Pharmaceuticals: MajorHealth Technology Develops novel locally administered formulations against dry mouth | Health Technology |
MarBiLeads AS
 MarBiLeads AS BiotechnologyHealth Technology Develops drugs for cancer and infections based on marine microogranisms | Health Technology |
Ola Flink Consulting AB |
